Design and synthesis of 2-(2-isonicotinoylhydrazineylidene)propanamides as InhA inhibitors with high antitubercular activity
Language English Country France Media print-electronic
Document type Journal Article
PubMed
34198149
DOI
10.1016/j.ejmech.2021.113668
PII: S0223-5234(21)00517-1
Knihovny.cz E-resources
- Keywords
- Antimycobacterial activity, InhA, Isoniazid, Mechanism of action, Multidrug resistance, Pyruvic acid, Tuberculosis,
- MeSH
- Amides chemistry metabolism pharmacology therapeutic use MeSH
- Aniline Compounds chemistry MeSH
- Antitubercular Agents chemical synthesis metabolism pharmacology therapeutic use MeSH
- Drug Resistance, Bacterial drug effects MeSH
- Bacterial Proteins antagonists & inhibitors metabolism MeSH
- Hep G2 Cells MeSH
- Pyruvic Acid chemistry MeSH
- Humans MeSH
- Microbial Sensitivity Tests MeSH
- Mycobacterium tuberculosis drug effects metabolism MeSH
- Oxidoreductases antagonists & inhibitors metabolism MeSH
- Drug Design * MeSH
- Tuberculosis drug therapy MeSH
- Cell Survival drug effects MeSH
- Structure-Activity Relationship MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- Amides MeSH
- Aniline Compounds MeSH
- Antitubercular Agents MeSH
- Bacterial Proteins MeSH
- InhA protein, Mycobacterium MeSH Browser
- Pyruvic Acid MeSH
- Oxidoreductases MeSH
Based on successful antitubercular isoniazid scaffold we have designed its "mee-too" analogues by a combination of this drug linked with substituted anilines through pyruvic acid as a bridge. Lipophilicity important for passive diffusion through impenetrable mycobacterial cell wall was increased by halogen substitution on the aniline. We prepared twenty new 2-(2-isonicotinoylhydrazineylidene)propanamides that were assayed against susceptible Mycobacterium tuberculosis H37Rv, nontuberculous mycobacteria, and also multidrug-resistant tuberculous strains (MDR-TB). All the compounds showed excellent activity not only against Mtb. (minimum inhibitory concentrations, MIC, from ≤0.03 μM), but also against M. kansasii (MIC ≥2 μM). The most active molecules have CF3 and OCF3 substituent in the position 4 on the aniline ring. MIC against MDR-TB were from 8 μM. The most effective derivatives were used for the mechanism of action investigation. The treatment of Mtb. H37Ra with tested compounds led to decreased production of mycolic acids and the strains overproducing InhA were more resistant to them. These results confirm that studied compounds inhibit the enoyl-acyl carrier protein reductase (InhA) in mycobacteria. The compounds did not show any cytotoxic and cytostatic activity for HepG2 cells. The amides can be considered as a promising scaffold for antitubercular drug discovery having better antimicrobial properties than original isoniazid together with a significantly improved pharmaco-toxicological profile.
References provided by Crossref.org
Synthesis and Antimycobacterial Activity of Isoniazid Derivatives Tethered with Aliphatic Amines